Company / Cash per Share
PharmaCyte Biotech, Inc. Cash per Share History
FY2023-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Cash per Share
$1.89
FY2025
5-year range
$1.89 / $3.28
FY2023-FY2025
Trend
-36.8%
vs FY2024
Sector context
Sector data unavailable
Latest sector comparison
What the data says
Declined from $3.28 to $1.89 over the past 2 years.
Based on SEC 10-K filings.
1.89 in FY2025.
Declined from $3.28 to $1.89 over the past 2 years.
Cash per Share over time
Growth rates
- 3-Year CAGR
- -
- 5-Year CAGR
- -
- 10-Year CAGR
- -
Key checks
Key Insights
- In FY2025, cash per share decreased 36.8% year-over-year.
Company context
Key Data Points
- Altman Z-Score 0.20 (distress zone, below 1.8 threshold)
- Low earnings quality (accrual-heavy earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Cash per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $1.89 | -36.8% |
| FY2024 | $2.99 | -9.0% |
| FY2023 | $3.28 | - |
| FY2022 | - | - |
| FY2021 | - | - |
| FY2020 | - | - |
| FY2019 | - | - |
| FY2018 | - | - |
| FY2017 | - | - |
| FY2016 | - | - |
As of FY2025 · SEC 10-K · Updated Jun 28, 2026